切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2017, Vol. 13 ›› Issue (04) : 490 -492. doi: 10.3877/cma.j.issn.1673-5250.2017.04.022

所属专题: 文献

综述

缺氧诱导因子-1α及可溶性血管内皮生长因子受体-1预测子痫前期的意义
单委1, 吴雅娟1, 蒋敏1   
  1. 1. 225001 江苏,扬州大学临床医学院妇产科
  • 收稿日期:2017-05-19 修回日期:2017-07-10 出版日期:2017-08-01

Significance of hypoxia inducible factor-1α and soluble fms-like tyrosine kinase receptor-1 in the prediction of preeclampsia

Wei Shan1, Yajuan Wu1, Min Jiang1   

  1. 1. Department of Obstetrics and Gynecology, Clinical Medical School, Yangzhou University, Yangzhou 225001, Jiangsu Province, China
  • Received:2017-05-19 Revised:2017-07-10 Published:2017-08-01
  • About author:
    Corresponding author: Lu Dan, Email:
引用本文:

单委, 吴雅娟, 蒋敏. 缺氧诱导因子-1α及可溶性血管内皮生长因子受体-1预测子痫前期的意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2017, 13(04): 490-492.

Wei Shan, Yajuan Wu, Min Jiang. Significance of hypoxia inducible factor-1α and soluble fms-like tyrosine kinase receptor-1 in the prediction of preeclampsia[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2017, 13(04): 490-492.

子痫前期(PE)是导致围生期母婴死亡的主要原因之一,其发病机制目前尚不明确。近年研究表明,缺氧诱导因子(HIF)-1α及可溶性血管内皮生长因子受体(sFlt)-1,是导致及加重PE症状的2个重要因子。在PE患者外周血及胎盘组织中,HIF-1α表达增多,可促使靶基因sFlt-1表达增多,从而促进并加重孕妇血管损伤、各脏器功能障碍及母婴并发症的发生。根据HIF-1α及sFlt-1的生物学功能及其在PE患者外周血及胎盘组织中的表达水平,可作为预测PE发生、孕产妇并发症发生情况及围生儿预后的指标之一,为PE的早期预防、早期治疗,以及降低母儿并发症及死亡率,提供新的理论依据和途径。

Preeclampsia (PE) is one of the main causes of maternal and infant death, but its pathogenesis has not been fully clarified. Recent studies have indicated that hypoxia inducible factor(HIF)-1α and soluble fms-like tyrosine kinase receptor (sFlt)-1 are the two important factors leading to and aggravating the symptoms of PE. With the expression of HIF-1α in peripheral blood and placenta tissue of PE patients increased, it would prompted the increased expression of target gene sFlt-1, which led to maternal vascular injury and organ dysfunction, and maternal and neonatal complications occur. According to the biological function of HIF-1α and sFlt-1, and their expression levels in peripheral blood and placenta tissue of PE patients, it can be one of the prediction indicators of the occurrence of PE, maternal complications and prognosis of perineonate for early prevention and treatment, and provide a theoretical basis and a new way to reduce maternal and neonatal complications and mortality.

[1]
谢幸,苟文丽. 妇产科学.8版[M]. 北京:人民卫生出版社,2013: 64-71.
[2]
刘静芳,刘国莉,王建六. 预测子痫前期发病相关因素的研究进展[J]. 现代妇产科进展,2013, 22(2): 159-162.
[3]
林其德,段涛,孔北华,等. 子痫前期-子痫相关问题的讨论[J]. 现代妇产科进展,2006, 15(9): 641-653.
[4]
Sun L, Liu Y, Lin S, et al. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor[J]. Acta Oncol, 2013, 52(4): 842-851.
[5]
Herraiz I, Simón E, Gómez-Arriaga P, et al. Angiogenesis-related biomarkers (sFlt-1/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration[J]. Int J Mol Sci, 2015, 16(8): 19009-19026.
[6]
Chang SD, Chao AS, Peng HH, et al. Analyses of placental gene expression in pregnancy-related hypertensive disorders[J]. Taiwan J Obstet Gynecol, 2011, 50(3): 283-291.
[7]
Zezza L, Ralli E, Conti E, et al. Hypertension in pregnancy: the most recent findings in pathophysiology, diagnosis and therapy[J]. Minerva Ginecol, 2014, 66(1): 103-126.
[8]
Hawfield A, Freedman BI. Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection[J]. Ther Adv Cardiovasc Dis, 2009, 3(1): 65-73.
[9]
Naicker T, Dorsamy E, Ramsuran D, et al. The role of apoptosis on trophoblast cell invasion in the placental bed of normotensive and preeclamptic pregnancies[J]. Hypertens Pregnancy, 2013, 32(3): 245-256.
[10]
彭文,王燕芸,贾颐舫. 子痫前期患者胎盘组织及外周血PLGF和sFlt-1的表达及作用机制[J]. 中国妇幼保健,2015, 30(26): 4559-4561.
[11]
Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation[J]. Mol Cell Biol, 1992, 12(12): 5447-5454.
[12]
Yamamoto Y, Ibusuki M, Okumura Y, et al. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer[J]. Breast Cancer Res Treat, 2008, 110(3): 465-475.
[13]
Wang GP, Zhang H, Zhang ZF, et al. Clinical and pathological characteristics of intraductal proliferative lesions and coexist with invasive ductal carcinomas[J]. Chinese-German J Clin Oncol, 2013, 12(12): 574-580.
[14]
Palmer KR, Kaitu′u-Lino TJ, Hastie R, et al. Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity[J]. Hypertension, 2015, 66(6): 1251-1259.
[15]
Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences[J]. J Clin Endocrinol Metab, 2003, 88(11): 5555-5563.
[16]
Henao DE, Cadavid AP, Saleem MA. Exogenous vascular endothelial growth factor supplementation can restore the podocyte barrier-forming capacity disrupted by sera of preeclamptic women[J]. J Obstet Gynaecol Res, 2013, 39(1): 46-52.
[17]
Chedraui P, Lockwood CJ, Schatz F, et al. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia[J]. J Matern Fetal Neonatal Med, 2009, 22(7): 565-570.
[18]
Ahamad S, Hewett PW, Al-Ani B, et al. Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis[J]. Vasc Cell, 2011, 3(1): 15.
[19]
Sezer SD, Küçük M, Döger FK, et al. VEGF, PIGF and HIF-1α in placentas of early- and late-onset pre-eclamptic patients[J]. Gynecol Endocrinol, 2013, 29(8): 797-800.
[20]
Akhilesh M, Mahalingam V, Nalliah S, et al. Hypoxia-inducible factor-1α as a predictive marker in pre-eclampsia[J]. Biomed Rep, 2013, 1(2): 257-258.
[21]
鲁晓燕,刘曼华,赵枰,等. 孕妇血清缺氧诱导因子1α水平与子痫前期病理特点的关系[J]. 山东医药,2013, 53(38): 64-65.
[22]
Giguère Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review[J]. Ann Biol Clin (Paris), 2011, 69(3): 257-271.
[23]
冯敏,杨海澜,王海燕,等. 血清及尿液中sFlt-1/PLGF比值的变化与子痫前期相关性研究[J]. 中国妇幼保健,2011, 26(6): 829-831.
[24]
陶娅玲,漆洪波. 子痫前期孕妇血清及尿液中VEGF、PLGF、sFlt-1水平变化及意义[J]. 实用妇产科杂志,2008, 24(8): 496-498.
[25]
Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia[J]. Hypertension, 2007, 50(1): 137-142.
[26]
Baltajian K, Hecht JL, Wenger JB, et al. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia[J]. Hypertens Pregnancy, 2014, 33(4): 427-439.
[1] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[2] 石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[3] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[4] 魏艺, 周羽西, 杨烨, 凌秀凤, 赵纯. 微小RNA对子宫内膜容受性影响的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 266-270.
[5] 林琳, 田思萌, 于永华, 徐飞飞, 黄明莉. 干细胞及其外泌体治疗宫腔黏连的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 271-275.
[6] 李欣, 魏艺, 张娟, 张娟娟, 凌秀凤, 赵纯, 张媔秋. 高龄女性冻胚移植周期临床妊娠结局的影响因素分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 276-283.
[7] 高伟聪, 李丽, 张中华, 朱向辉, 刘素巧. 宫颈癌患者糖调节受损对改良根治术后2年内复发的影响作用[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 231-237.
[8] 杨琳, 尹如铁. 外阴白色病变病因研究及治疗现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 157-165.
[9] 王丽, 王月莺, 周芬, 郭宇堃, 魏丽娜. 促性腺激素释放激素拮抗剂对子宫内膜容受性影响的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 629-635.
[10] 武渊, 朱必清, 何丹, 王海蓉, 李倩. 采取调强放疗联合后装治疗宫颈癌患者的预后模型及危险分层系统构建[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 734-744.
[11] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[12] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[13] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[14] 周东杰, 蒋敏, 范海瑞, 高玲玲, 孔祥, 卢丹, 王丽萍. 非编码RNA在卵泡发育成熟中作用及其机制的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 387-393.
[15] 刘佳, 付丽, 杨月美. miR-138-5p调节HIF-1α/Notch1轴对滋养层细胞侵袭和血管生成的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2023, 13(05): 277-287.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?